AzTrials
AzTrials

Wear of Articular Bearing Surface of Prosthetic JointCS vs CR RSANCT05936593

Migration of CS vs CR Insert in TKA Using RSA

A study testing Condylar Stabilizing (CS) insert and Cruciate Retaining (CR) insert in people with Wear of Articular Bearing Surface of Prosthetic Joint and Migration of Implant, run by Reinier Haga Orthopedisch Centrum at 1 site in Netherlands.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Background: The choice whether or not to preserve the posterior cruciate ligament (PCL) in total knee arthroplasty (TKA) is coupled to the us of a PCL-retaining (CR) or a condylar (CS) insert. Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
Condylar Stabilizing (CS) insert and Cruciate Retaining (CR) insert
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteNetherlands
Study dates
21 Jul 2023to Jun 2035
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients scheduled to undergo primary total knee replacement with the MAKO-robotic arm, with one of the following indications:
  • Painful, disabling joint disease of the knee resulting from: non-inflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis or avascular necrosis) or rheumatoid arthritis.
  • One or more compartments are involved;
  • Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability (meaning a varus, valgus or flexion deformity < 15 degrees);
  • Age between 18 and 70 years;
  • ASA score I or II;
Show all 10Show fewer
  • A good nutritional state of the patient;
  • Patients with a completely intact PCL at the time of surgery;
  • Patient is able to understand the study and is willing to participate and to sign the Informed Consent;
  • Patient is able to speak and write Dutch.

Who cannot join

  • Contraindications manufacturer:
  • Any active or suspected latent infection in or about the knee joint;
  • Distant foci of infection which may cause hematogenous spread to the implant site;
  • Any mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complications in postoperative care;
  • Bone stock compromised by disease, infection or prior implantation which cannot provide adequate support and/or fixation to the prosthesis;
  • Skeletal immaturity;
Show all 27Show fewer
  • Severe instability of the knee joint secondary to the absence of collateral ligament integrity and function;
  • Metal in the operative or non-operative leg which lead to the creation of accuracy-reducing artefacts in the CT scan;
  • Body Mass Index (BMI) of > 35 kg/m2;
  • Flexion contracture of 15 degrees and more;
  • Varus/valgus contracture of 15 degrees and more;
  • History of total or unicompartmental reconstruction of the affected joint;
  • Bilateral operation;
  • A Total Hip Arthroplasty (THA) on contralateral and/or ipsilateral side within the last year that is considered to have an unsatisfactory outcome (Patients with contralateral and/or ipsilateral THA > 1 year ago with good outcome can be included in the study);
  • A Total Knee Arthroplasty (TKA) on contralateral side within the last 6 months that is considered to have an unsatisfactory outcome. (Patients with contralateral TKA > 6 months ago with good outcome can be included in the study);
  • Patients who will need lower limb joint replacement for another joint within one year.
  • Active or suspected latent infection in or about the knee joint;
  • Osteomyelitis;
  • Sepsis;
  • A systemic or metabolic disorder leading to progressive bone deterioration, excluding rheumatoid arthritis;
  • Vascular insufficiency, muscular atrophy;
  • Neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device;
  • Female patients planning a pregnancy during the course of the study;
  • The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
  • Patients bone stock is compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis;
  • A knee fusion to the affected joint;
  • Patient has a known or suspected sensitivity or allergy to one or more of the implant materials;

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Netherlands1 site, 1 recruiting
  • Reinier Haga Orthopedisch Centrum

    Zoetermeer, South Holland, 2725 NA

    J. Pasma, 079 - 206 5595, Onderzoek@rhoc.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Migration in a Cruciate Retaining and a Condylar Stabilizing Insert of a Robot-assisted Uncemented Total Knee Prosthesis Using Model-based RSA: a Mono-Center Randomized Controlled Trial With 10 Years Follow-up

Background:

The choice whether or not to preserve the posterior cruciate ligament (PCL) in total knee arthroplasty (TKA) is coupled to the us of a PCL-retaining (CR) or a condylar (CS) insert. The CS insert is anterior-lipped (AL) to prevent anterior translation of the femur on the tibia with flexion and compensate the function of the PCL. Currently both the CR and CS insert are made of highly cross-linked polyethylene (HXPLE) to theoretically reduce wear related osteolysis. However, this also might diminish the fracture toughness and crack propagation of the insert. The investigators expect that due to the high contact forces on the anterior lip of the CS insert during flexion, especially in younger and more active patients, and the lower fracture toughness of HXPLE, the CS insert insert might show more migration, wear or other damage compared to the CR insert in the long-term, which might lead to more revisions in the CS insert compared to the CR insert.

Read more

To measure the migration and wear, during surgery tantalum markers will be inserted in the host bone using a marker inserter. The displacement of the prosthesis with reference to the host bone will be measured using model-based RSA. Both tantalum markers ande the inserter are already used for study purposes. However, the safety and usability are not registered before.

Objective:

The primary objective is to compare the migration of both the femoral and tibial component by the use of a CS insert or CR insert both made of HXPLE using model-based roentgen stereophotogrammetric analysis (mRSA). Furthermore, the safety and usability of the tantalum markers and the marker inserter will be determined. The secondary objective is to determine the influence of the type of insert on the wear, inducible displacement, survival and clinical outcomes.

Study design:

A randomized controlled trial

Study population:

Forty-four patients scheduled to undergo primary total knee replacement, aged below 70 years with an ASA-score of 1 or 2 will be needed in total, divided in two groups of 22 patients each.

Intervention:

One group receives an uncemented TKP with a CS insert, while the other group receives an uncemented TKP with a CR insert. Both will be placed using the MAKO-robotic arm using a kinematic balancing technique.

Outcomes:

Main study parameters are migration of the femoral and tibial components measured with model-based RSA software till 10 years postoperatively. Furthermore, the stability of the markers will be determined and the complications due to the markers and/or the marker inserter will be registered. The secondary parameters are wear, inducible displacement, survival, clinical outcomes and complications up to 10 years postoperatively.

Being tested
Condylar Stabilizing (CS) insert, Cruciate Retaining (CR) insert
Keywords
Total knee arthroplasty, Insert

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Condylar Stabilizing (CS) insertDevice

    During TKA surgery a Condylar Stabilizing (CS) insert is implanted and tantalum beads are placed around the prosthesis.

  • Cruciate Retaining (CR) insertDevice

    During TKA surgery a Cruciate Retaining (CR) insert is implanted and tantalum beads are placed around the prosthesis.

Study groups in NCT05936593
Study groupRoleWhat they receive
Condylar Stabilizing (CS) insertActive comparatorNot described
Receives: Device: Condylar Stabilizing (CS) insert
Cruciate Retaining (CR) insertActive comparatorNot described
Receives: Device: Cruciate Retaining (CR) insert

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Translations (mm)

    The translations of the femoral and tibial components measured in 3 axis (z, y and z) with model-based RSA over 10 years.

    Measured: 10 years after surgery

  2. Rotations (degrees)

    The rotations of the femoral and tibial components measured in 3 axis (z, y and z) with model-based RSA over 10 years.

    Measured: 10 years after surgery

  3. Stability of the tantalum markers

    Stability of the tantalum markers will be determined by the mean error value of the markers.

    Measured: 10 years after surgery

  4. Safety of the tantalum markers and the inserter

    Safety of the tantalum markers are determined by registration of the complications due to the markers and/or marker inserter. Complications will be expressed by numbers and percentages.

    Measured: 10 years after surgery

Secondary outcomes (11)
  1. Wear

    Wear of the insert measures in 3 axis (x, y and z)

    Measured: 10 years after surgery

  2. Inducible displacement (mm)

    The inducible displacement gives insight into the nature and durability of the fixation and is defined as the micromotion occurring in response to external forces. The inducible displacement will be expressed by translations (x-, y- and z-direction) in mm

    Measured: 10 years after surgery

  3. Inducible displacement (degrees)

    The inducible displacement gives insight into the nature and durability of the fixation and is defined as the micromotion occurring in response to external forces. The inducible displacement will be expressed by rotations (x-, y- and z-direction) in degrees.

    Measured: 10 years after surgery

  4. Survival

    Survival of the CS and CR inserts is measured by registration of all complications and is expressed by numbers and percentages.

    Measured: 10 years after surgery

  5. Clinical outcomes: Knee Society Score (KSS)

    The Knee Society Score (KSS) is a questionnaire to rate the knee prosthesis function. A high score means a good function and a low score means a worse function. The score varies between 0 and 100.

    Measured: 10 years after surgery

  6. Clinical outcomes: Numeric Rating Scale for pain (NRS pain)

    The Numeric Pain Rating Scale (NRS) measures the amount of pain experienced in the past week during rest and activity. It is a scale from 0 (no pain) to 10 (worst pain imaginable)

    Measured: 10 years after surgery

  7. Clinical outcomes: EuroQol 5D (EQ-5D-5L)

    The EuroQol-5D-5L (EQ-5D-5L) is a questionnaire that describes the overall health condition of the person. The score is given by an index consisting of 5 numbers, which represents a health status. A lower score indicates a good condition. The last question of this questionnaire is the overall health condition of the person on a scale of 0 to 100. In this question a higher score indicates a good condition.

    Measured: 10 years after surgery

  8. Clinical outcomes: Knee Injury and Osteoarthritis Outcome Score (short version, KOOS-PS)

    The Knee Injury and Osteoarthritis Outcome Score - short version (KOOS-PS) is a questionnaire about the ability to perform normal daily activities. A high score means that the activities cost a lot of effort to perform, while a low score means that the activities can be done with minimum effort. The score varies between 0 and 100.

    Measured: 10 years after surgery

  9. Clinical outcomes: Forgotten Joint Score (FJS)

    The Forgotten Joint score (FJS) is a questionnaire about the awareness of the prosthetic knee. A high score means a low awareness and a low score means a high awareness. The score varies between 0 and 100.

    Measured: 10 years after surgery

  10. Clinical outcomes: Numeric Rating Scale for Satisfaction (NRS satisfaction)

    The satisfaction is a single question about the overall satisfaction of the result of the surgery on a scale from 0 (very unsatisfied) to 10 (very satisfied).

    Measured: 10 years after surgery

  11. Clinical outcomes: Oxford Knee Score (OKS)

    The Oxford Knee Score (OKS) is a questionnaire about the amount of influence of the operated knee on the persons life. A low score means that the life of the person is influenced a lot by the operated knee, while a high score means that the life of the persons is little influenced by the operated knee. The score varies between 0 and 48.

    Measured: 10 years after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2023
  2. Study start21 Jul 2023
  3. Primary completionJun 2035 (estimated)
  4. Study completionJun 2035 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
44 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05936593
Sponsor's protocol ID
OC-2021-004
Acronym
CS vs CR RSA
Status last verified
Dec 2023
First submitted
12 Jun 2023
Last updated
18 Dec 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Condylar Stabilizing (CS) insert and Cruciate Retaining (CR) insert in people with Wear of Articular Bearing Surface of Prosthetic Joint and Migration of Implant, run by Reinier Haga Orthopedisch Centrum at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 27 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact J. Pasma (079 - 206 5595, Onderzoek@rhoc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Translations (mm) (time frame: 10 years after surgery). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2023; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in